期刊文献+

ALTERNATING CHEMOTHERAPY AND FRACTIONATED RADIOTHERAPY AS A MODALITY FOR THE TREATMENT OF PRIMARY LIVER CANCER 被引量:1

ALTERNATING CHEMOTHERAPY AND FRACTIONATED RADIOTHERAPY AS A MODALITY FOR THE TREATMENT OF PRIMARY LIVER CANCER
下载PDF
导出
摘要 Alternating chemotherapy and fractionated radiotherapy were carried out in 32 patients with surgically proven unresectable primary liver cancer (PLC).After initial surgical intervention of hepatic artery ligation and cannulation,the tumor war localized with silver clips.The cisplatin 20 mg was infused via a hepatic artery catheter per day on the first 3 consecutive days.Fractionated radiation(18MV straight linear accelerator)of 250 cGy,twice a day with an interval of 6 hours,was then followed on the 8th,9th and 10th days.The cycle was repeated 3 or 4 times.The shrinkage of tumors and decrease of AFP level were observed in 100%(32/32)and 5% (19/21)of the patients respectively.A second-stage resection was done in 37.5%(12/32)of the patients.The 1-,3- and 5-year survival rates after resection were 96.7% ,67.5% and 67. 5 % respectively.It is suggested that this modality is a choice of therapies which can convert some unresectable large PLC to resectable ones. Alternating chemotherapy and fractionated radiotherapy were carried out in 32 patients with surgically proven unresectable primary liver cancer (PLC).After initial surgical intervention of hepatic artery ligation and cannulation,the tumor war localized with silver clips.The cisplatin 20 mg was infused via a hepatic artery catheter per day on the first 3 consecutive days.Fractionated radiation(18MV straight linear accelerator)of 250 cGy,twice a day with an interval of 6 hours,was then followed on the 8th,9th and 10th days.The cycle was repeated 3 or 4 times.The shrinkage of tumors and decrease of AFP level were observed in 100%(32/32)and 5% (19/21)of the patients respectively.A second-stage resection was done in 37.5%(12/32)of the patients.The 1-,3- and 5-year survival rates after resection were 96.7% ,67.5% and 67. 5 % respectively.It is suggested that this modality is a choice of therapies which can convert some unresectable large PLC to resectable ones.
出处 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 1994年第1期69-73,共5页 中国癌症研究(英文版)
关键词 Fractionated radiotherapy CHEMOTHERAPY CISPLATIN Primary liver cancer Second-stage resection. Fractionated radiotherapy,Chemotherapy,Cisplatin,Primary liver cancer,Second-stage resection.
  • 相关文献

参考文献1

共引文献8

同被引文献14

  • 1林金芳,孙翠翔,郑怀美.Gonadotropin releasing hormone agonists and laparoscopy in the treatment of adenomyosis with infertility[J].Chinese Medical Journal,2000(5):58-61. 被引量:7
  • 2Funda Meric MD,Yehuda Z. Patt MD,Steve A. Curley MD,Judy Chase PharmD,Mark S. Roh MD,J. Nicolas Vauthey MD,Lee M. Ellis MD.Surgery After Downstaging of Unresectable Hepatic Tumors With Intra-Arterial Chemotherapy[J]. Annals of Surgical Oncology . 2000 (7)
  • 3Zhao-You Tang M.D.,Ye-Qin Yu M.D.,Xin-Da Zhou M.D.,Zeng-Chen MA M.D.,Ji-Zheu Lu M.D.,Zhi-Ying Lin M.D.,Kang-Da Liu M.D.,Sheng-Long Ye M.D.,Bing-Hui Yang M.D.,Hong-Wei Wang M.D.,Hui-Chuan Sun M.D..Cytoreduction and sequential resection for surgically verified unresectable hepatocellular carcinoma: Evaluation with analysis of 72 patients[J]. World Journal of Surgery . 1995 (6)
  • 4Zhao-You Tang M.D.,Ye-Qin Yu M.D.,Xin-Da Zhou M.D.,Zeng-Chen Ma M.D.,Bing-Hui Yang M.D.,Zhi-Ying Lin M.D.,Ji-Zhen Lu M.D.,Kang-Da Liu M.D.,Zeng Fan M.D.,Zhao-Chong Zeng M.D..Treatment of unresectable primary liver cancer: With reference to cytoreduction and sequential resection[J]. World Journal of Surgery . 1995 (1)
  • 5Brans B,De Winter F,Defreyne L,Troisi R,Vanlangenhove P,Van Vlierberghe H, et al.The anti-tumoral activity of neo- adjuvant intra-arterial 131 I-lipiodol treatment for hepatocellular carcinoma: a pilot study. Cancer Biotherapy and Radiopharmaceuticals . 2001
  • 6Majno PE,Adam R,Bismuth H,Castaing D,Ariche A,Krissat J, et al.Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepato- cellular carcinoma in patients with cirrhosis. Annals of Surgery . 1997
  • 7Patt YZ,Hassan MM,Lozano RD,Brown TD,Vauthey JN,Curley SA, et al.Phase II trial of systemic continuous fluorou- racil and subcutaneous recombinant interferon Alfa-2b for treat- ment of hepatocellular carcinoma. Journal of Clinical Oncology . 2003
  • 8Sitzmann JV,Abrams R.Improved survival for hepatocellular cancer with combination surgery and multimodality treatment. Annals of Surgery . 1993
  • 9Tang ZY,Yu YQ.Long-term survival of hepatocellular carci- noma with reference to the role of early resection, multiopera- tion and multimodality treatment. Gann Monograph on Cancer Research . 1986
  • 10Tang ZY,Yu YQ,Zhou XD,Ma ZC,Lu JZ,Liu KD, et al.Cytoreduction and sequential resection; A hope for unre- sectable primary liver cancer. Journal of Surgical Oncology . 1991

引证文献1

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部